The net cash of Yield10 Bioscience with headquarters in the United States amounted to -10.07 million U.S. dollars in 2023. The reported fiscal year ends on December 31.

Compared to the earliest depicted value from 2019 this is a total decrease by approximately 1.42 million U.S. dollars. The trend from 2019 to 2023 shows, however, that this decrease did not happen continuously.